Quantcast
Last updated on April 20, 2014 at 8:07 EDT

Latest Regenerative biomedicine Stories

2010-08-13 14:16:26

The American Society of Hematology (ASH) has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine." Regenerative medicine is a multidisciplinary approach to treating diseases and disorders by...

2010-07-12 07:42:00

NEW YORK, July 12 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that it has been awarded a $700,000 contract from the U.S. Army Medical Research and Materiel Command, Telemedicine and Advanced Technology Research Center (USAMRMC-TATRC) under U.S. Army Medical Research Acquisition Activity contract number: (W81XWH-10-2-0039). This contract is for...

2010-07-01 08:04:00

AUSTIN, Texas, July 1 /PRNewswire/ -- SpineSmith Partners and Celling Technologies hired Brian Burkinshaw as Vice President of Research and Development, strengthening the company's position as an industry leader in adult stem cell technology innovations. Burkinshaw will lead SpineSmith's product development efforts through the collaboration of the company's mechanical engineering department and Celling Technologies' team of scientists. These teams work closely with surgeons to develop...

2010-06-10 10:40:00

In the news release, "Beike Biotech Launches New International Stem Cell Venture," issued earlier today by Shenzhen Beike Biotechnology Co. Ltd. over PR Newswire, we are advised by the company that the first sentence of the second paragraph should read, "Beike's stem cells have been shown to be safe and effective in therapies based on direct clinical observation in the hospital setting," rather than, "In China, Beike's use of cord blood and tissue-derived stem cells is approved by the...

2010-06-10 09:00:00

SHENZHEN, China, June 10 /PRNewswire-Asia/ -- Shenzhen Beike Biotechnology Co. Ltd. ("Beike") ( http://www.beikebiotech.com ), China's leading stem cell research and regenerative medicine company, announced the formation of Beike Holdings Limited ("Beike Holdings") a joint venture with Bangkok-based SiriCell Technologies, Inc. Beike Holdings, which is headquartered in Bangkok, Thailand, will focus primarily on the establishment of new international subsidiaries and the development of...

2010-05-27 15:01:00

NEW YORK, May 27 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced that the Company has been invited to present its adult stem cell technologies at the Stem Cell Investor & Executive Networking Conference Event (SCIENCE) in New York City on June 1, 2010. SCIENCE is designed to bring together investors with industry executives, visionary researchers and...

2010-04-05 07:00:00

CLEVELAND, April 5 /PRNewswire/ -- Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac function by promoting cell survival and increasing new blood...

2010-03-30 15:05:00

SUNRISE, Fla., March 30 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) announced today that Dr. Karl E. Groth, the Company's Chairman and CEO will speak at the 2010 Translational Regenerative Medicine Forum in Winston-Salem, North Carolina, on April 8. Dr. Groth will discuss Bioheart's cell therapies for Congestive Heart Failure. Bioheart's therapies, which are currently in trials all over the world, aim to bring to patients, who otherwise would have little hope for...

8030dbc52985ad98e5fbacd8c4f6a4681
2010-03-21 07:10:00

British Italian doctors said they have carried out groundbreaking surgery to help rebuild the windpipe of a 10-year-old boy by using stem cells developed from his own body. Doctors at London's Great Ormond Street Children's Hospital implanted the boy with a donor trachea that had been stripped of its cells and injected with his own.  The operation took place last week and lasted nearly nine hours. Doctors expect the boy's bone marrow stem cells to begin transforming themselves over the...

2010-03-19 09:22:00

WINSTON-SALEM, N.C., March 19 /PRNewswire-USNewswire/ -- The Regenerative Medicine Foundation is pleased to announce a special "Young Minds" graduate student registration rate for its annual Translational Regenerative Medicine Forum, set for April 6-8 in Winston-Salem. The forum is an annual event to convene the regenerative medicine community to focus on fulfilling the promise of the field, including best practices and business models. Keynote speakers and panelists will discuss...


Latest Regenerative biomedicine Reference Libraries

The Axolotl, Ambystoma mexicanum
2014-02-03 08:59:54

Axolotl (Ambystoma mexicanum) may also be referred to as the Mexican salamander or the Mexican walking fish. The Axolotl is a member of the Ambystomatidae family and although its common name may suggest it is a fish, it is an amphibian. Axolotl are found exclusively in Mexico. The species situates, near Mexico City, on the bottom of Xochimilco’s lakes. Unlike most salamanders, Axolotl keep its larval features throughout its entire life and very rarely ever emerge from water. A condition...

More Articles (1 articles) »